ABRF 2022 Annual Meeting
Palm Springs, CA
March 27 – March 30
As the largest international organization representing shared resource cores, the ABRF Annual Meeting is not to be missed! There are so many opportunities to network with core laboratory professionals of all disciplines learn about the latest groundbreaking research and instrumentation and develop a new set of skills.
Date/Time: March 28th, 1 PM
Presentation title: Enabling scalable cell engineering using the MaxCyte ExPERT electroporation platform
What you will learn:
MaxCyte is a U.S.-based global company leveraging its proprietary electroporation technology to accelerate the discovery, development, manufacturing and commercialization of next-generation medicines. During this presentation, we will explore how MaxCyte’s unique electroporation technology enables highly efficient, scalable engineering of cell lines and primary cells for a range of applications, including transient protein production, cell line development, and cell therapy manufacturing. We will showcase how our partners utilize the MaxCyte platform to shorten timelines, reduce cost, and de-risk cell engineering processes from concept to commercialization.
Andrew Mancini, Ph.D.
Field Application Scientist
Andrew Mancini is a Field Application Scientist at MaxCyte specializing in Cell and Gene Therapy. As a field-based scientist, Andrew works closely with MaxCyte’s partners around the world to develop novel cell engineering workflows for the development of cellular therapeutics. Prior to his time at MaxCyte, Andrew completed his PhD in Biomedical Sciences at the University of California, San Francisco and completed his postdoctoral training at Genentech in Molecular Oncology. He has broad range of experience and expertise that encompasses non-viral and viral engineering of primary immune cells, stem cells, and cell lines at both research and manufacturing scales.